Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Beta-1,3′-galactosyllactose for the treatment of gut barrier function diseases

Beta-1,3′-galactosyllactose for the treatment of gut barrier function diseases

US Patent 12508273 · Granted Dec 30, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition with non-digestible oligosaccharides for attenuating nasal epithelia2024
Nutritional composition for improving intestinal barrier integrity, preparation 2023
Human milk oligosaccharide for improving immune fitness2023
Method for inducing oral tolerance via administration of beta-lactoglobulin deri2022
Fucosyllactose as breast milk identical non-digestible oligosaccharide with new 2021
Fucosyllactose as breast milk identical non-digestible oligosaccharide with new 2021
Mixture of non-digestible oligosaccharides for stimulating the immune system2021
Mixture of non-digestible oligosaccharides for stimulating the immune system2021
Intestinal barrier integrity2021
Fucosyllactose as breast milk identical non-digestible oligosaccharide with new 2020
Fucosyllactose as breast milk identical non-digestible oligosaccharide with new 2020
Intestinal barrier integrity2019